Imperial College London Archives – Cambridge Enterprise

Pioneering portfolio company Apollo Therapeutics closes $226.5 million round to translate fundamental medical research into medicines

06 September 2023

Developing policy structures to help the UK maximise impact from research

Leading universities and VCs publish unique USIT Guide to accelerate university spin-outs and boost UK growth

Apollo Therapeutics: KE Award Winners

Female scientist looking down a telescope

Apollo Therapeutics: Pioneering collaboration launches its next phase

10 February 2022

Pipette for Apollo Therapeutics launch

Apollo Therapeutics launches as multinational company, backed by £100m investment

Coronavirus (COVID) abstract image

Top US, UK, and EU universities work together to help economies fuel post-COVID recovery

18 September 2020

An update from Apollo Therapeutics

22 February 2017

Apollo: industry expertise and pharma muscle drives science to the clinic with unparalleled speed

09 February 2016

Cambridge joins consortium to launch £40 million Apollo fund to drive therapeutic innovation

25 January 2016